About Agios (AGIO)
Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... Read more
- USD27.52
- USD27.66
- USD26.78
- USD46.00
- -37.50%
- 45M
- 1.20M
- 1.97M
- 1.6B
- 22.24
- -28.60%
Stock News
3 hours ago
Broadcom and Costco's rich valuations leave little room for error as battleground stocks
CNBC
4 hours ago
Kyverna Therapeutics to Report Topline Results from Registrational Phase 2 KYSA-8 Trial of KYV-101 in Stiff Person Syndrome
Yahoo
6 hours ago
Stocks risk a stir-up in last trading push of the year. Where to put your money.
MarketWatch
7 hours ago
Here are the 2 big things we're watching in the stock market this week
CNBC